Morris J C, Ping-Sheng L, Zhai H X, Shen T Y, Mensa-Wilmot K
Department of Cellular Biology, The University of Georgia, Athens, Georgia 30602, USA.
J Biol Chem. 1996 Jun 28;271(26):15468-77. doi: 10.1074/jbc.271.26.15468.
Phosphatidylinositol-specific phospholipase C (PI-PLC) from Bacillus cereus is inhibited by myo-inositol-1-O-dodecylphosphonate (Ins-1-O-dodecylphosphonate) (Morris, J. C., Ping-Sheng, L., Shen, T. Y., and Mensa-Wilmot, K.(1995) J. Biol. Chem. 270, 2517-2524). A set of novel fluorinated 2-deoxy-Ins-1-O-dodecylphosphonates were tested against PI-PLC, with potent competitive inhibition by 2-deoxy-2-fluoro-scyllo-Ins-1-O-dodecylphosphonate (VP-616L) (Xi(50) = 0.09). 2-Deoxy-2-fluoro-myo-Ins-1-O-dodecylphosphonate and 2-deoxy-2,2-difluoro-myo-Ins-1-O-dodecylphosphonate were 8.3-fold and 4.8-fold less effective, respectively, than VP-616L. Methyl 2-deoxy-2,2-difluoro-myo-Ins-1-O-dodecylphosphonate was inactive. Also, a hundredfold less PI-PLC is required to cleave a glycosylphosphatidylinositol (GPI) than is needed to cleave PI. Implied in these observations are the following: (i) in powerful inhibitors an active site residue probably interacts with the equatorially oriented fluoro substituent; (ii) substrate recognition requires a negative charge on the phosphoryl at the Ins-1 position, and (iii) a GPI is better substrate than PI, for PI-PLC. Aminoglycoside antibiotics kanamycin A, gentamycin, and G418 stimulated PI-PLC cleavage of the GPI anchor of variant surface glycoprotein (VSG) from Trypanosoma brucei 2- to 4-fold. G418, which appears to act on the enzyme.substrate complex, increased kcat and Km 6.4-fold and 9.9-fold, respectively. PI-PLC was activated by G418 even in the presence of the inhibitor VP-616L. In control experiments, the lectin concanavalin A (ConA), which probably acts by substrate sequestration, inhibited both PI-PLC (Xi(50) = 0.00025) and GPI-specific phospholipase D (Xi(50) = 0.00018). G418 failed to activate PI-PLC when ConA was present. These observations indicate that G418 is an allosteric activator of Bacillus cereus PI-PLC. Since G418 stimulates a purified enzyme that is not involved in aminoglycoside metabolism, we propose that binding of aminoglycosides to cellular proteins could contribute to the development of the nephrotoxicity associated with the use of these aminoglycoside antibiotics.
蜡样芽孢杆菌的磷脂酰肌醇特异性磷脂酶C(PI-PLC)受到肌醇-1-O-十二烷基膦酸酯(Ins-1-O-十二烷基膦酸酯)的抑制(莫里斯,J.C.,平盛,L.,沈,T.Y.,和门萨-威尔莫特,K.(1995年)《生物化学杂志》270,2517 - 2524)。一组新型的氟化2-脱氧-Ins-1-O-十二烷基膦酸酯针对PI-PLC进行了测试,其中2-脱氧-2-氟异肌醇-1-O-十二烷基膦酸酯(VP-616L)具有强效的竞争性抑制作用(半数抑制浓度(Xi(50)) = 0.09)。2-脱氧-2-氟肌醇-1-O-十二烷基膦酸酯和2-脱氧-2,2-二氟肌醇-1-O-十二烷基膦酸酯的效力分别比VP-616L低8.3倍和4.8倍。2-脱氧-2,2-二氟肌醇-1-O-十二烷基膦酸甲酯没有活性。此外,裂解糖基磷脂酰肌醇(GPI)所需的PI-PLC比裂解PI所需的量少一百倍。这些观察结果暗示如下:(i)在强效抑制剂中,一个活性位点残基可能与赤道取向的氟取代基相互作用;(ii)底物识别需要Ins-1位磷酰基上带负电荷,以及(iii)对于PI-PLC而言,GPI是比PI更好的底物。氨基糖苷类抗生素卡那霉素A、庆大霉素和G418使布氏锥虫变异表面糖蛋白(VSG)的GPI锚定物的PI-PLC裂解增加2至4倍。似乎作用于酶 - 底物复合物的G418分别使催化常数(kcat)和米氏常数(Km)增加了6.4倍和9.9倍。即使在存在抑制剂VP-616L的情况下,G418也能激活PI-PLC。在对照实验中,可能通过底物隔离起作用的凝集素伴刀豆球蛋白A(ConA)抑制了PI-PLC(半数抑制浓度(Xi(50)) = 0.00025)和GPI特异性磷脂酶D(半数抑制浓度(Xi(50)) = 0.00018)。当存在ConA时G418未能激活PI-PLC。这些观察结果表明G418是蜡样芽孢杆菌PI-PLC的变构激活剂。由于G418刺激一种不参与氨基糖苷代谢的纯化酶,我们提出氨基糖苷类与细胞蛋白的结合可能导致与使用这些氨基糖苷类抗生素相关的肾毒性的发展。